(Q36106487)

12 August 2017

1 reference

title

Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies (English)

1 reference

12 August 2017

Caldecott-Hazard S

1

1 reference

PubMed ID

1585257

12 August 2017

Schneider LS

series ordinal

2

1 reference

PubMed ID

1585257

12 August 2017

language of work or name

1 reference

1 February 1992

1 reference

12 August 2017

1 reference

12 August 2017

10

1 reference

12 August 2017

2

1 reference

12 August 2017

141-168

1 reference

The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review

12 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

The use of psychostimulants in general psychiatry. A reconsideration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Maprotiline treatment in depression. A perspective on seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Differential Symptom Reduction by Drugs and Psychotherapy in Acute Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

National Institute of Mental Health Treatment of Depression Collaborative Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Depression and MHPG excretion. Response to dextroamphetamine and tricyclic antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Bupropion in depression. II. The role of metabolites in clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Lithium-antidepressant combinations in the treatment of depressed, physically ill geriatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Phenelzine v imipramine in atypical depression. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Imipramine and chlordiazepoxide in depressive and anxiety disorders. I. Efficacy in depressed outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Trazodone in the treatment of panic disorder and agoraphobia with panic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Homovanillic and 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid of Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Psychomotor Activity and Cerebrospinal Fluid Amine Metabolites in Affective Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Duration of antidepressant drug treatment. What is an adequate trial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

l-Deprenyl in atypical depressives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Changes in primate social behavior after treatment with alpha-methyl-para-tyrosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Tricyclic antidepressants in depressed patients with cardiac conduction disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Disposition kinetics of moclobemide, a monoamine oxidase-A enzyme inhibitor: single and multiple dosing in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Parachlorophenylalanine Reversal of Tranylcypromine Effects in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters. A follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Thyroid Function and the Response to Liothyronine in Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Prediction of imipramine antidepressant response by a one-day dextro- amphetamine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Clinical Effects of the 5-HT1A Partial Agonists in Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Lithium in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Cognitive-behavioral treatment of depressed inpatients: six- and twelve-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Seasonal affective disorder in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Antidepressant effects of light in seasonal affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Cholinergic regulation of mood and REM sleep: potential model and marker of vulnerability to affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Alprazolam-induced manic episode in two patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890100209

21 January 2018

Identifiers

DOI

10.1002/SYN.890100209

1 reference

12 August 2017

1 reference

PubMed ID

1585257